* Regeneron and Sanofi announce approval of
praluent (alirocumab) for the treatment of hypercholesterolemia
in Japan
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
The post BRIEF-Regeneron and Sanofi announce approval of praluent (alirocumab) in Japan appeared first on NASDAQ.